MarketsandMarkets: H1N1 (Swine Flu) Influenza Vaccine Market Worth US$ 7,028 Million By 2011
Wilmington,Del.- A new market research report, ‘Global H1N1 2009 Influenza Vaccine’, published by MarketsandMarkets (www.marketsandmarkets.com) analyzes the global H1N1 2009 Influenza vaccine market over the period 2009-2012. The report studies the major market drivers, restraints, and opportunities for global H1N1 2009 Influenza vaccine market and also evaluates the major pandemic trends with respect to different geographic regions.
Browse in-depth TOC on stem cell market. Early buyers will receive 10% customization of report.
http://www.marketsandmarkets.com/Market-Reports/influenza-vaccines-market-159.html
The global H1N1 2009 Influenza vaccine market is estimated to be $7,028 billion by 2011, growing at a CAGR of 222.4 % from 2009 to 2011. Some of the key players in this market are GlaxoSmithKline, Novartis, CSL, MedImmune, Sanofi-Pasteur, Solvay, Sinovac Biotech and Hualun Biologicals.
The global H1N1 2009 Influenza vaccine market is growing due to the prevailing pandemic of H1N1 influenza and huge demand from different countries for the vaccines against it. The H1N1 Influenza vaccine market is mainly driven by the increasing awareness of the population, global spread of H1N1 influenza and the initiatives taken by government & other public institutions for immunization of the population against H1N1 influenza. The North America region is the current lucrative market for H1N1 influenza vaccines with other regions also having high infection rate across the population.
Due to intensive ongoing research and technology introduction, the market players are compelled to understand the market dynamics, innovations, pricing, products, marketing and regulatory framework of the market.
SCOPE AND FORMAT
This report will enable strategic understanding and opportunities in the H1N1 2009 influenza vaccines market. The report covers the following market segments.
Vaccines Markets: Intramuscular Vaccines and Intranasal vaccines.
Geography Markets: North America, Europe, Asia-Pacific and ROW
Each section of the report offers market data with respect to segments and geography. It also provides market trends with respect to drivers, restraints and opportunities. The report contains strategic section with respect to competitive landscape and market overview. The report will encompass around 15 company profiles.
Analyst Briefings on 27th Oct 2009
The Healthcare practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on the Opportunity Analysis- H1N1 (Swine Flu) Vaccination Market (2009-2012) to be held on 27th Oct 2009
To register your participation, please click here
http://www.marketsandmarkets.com/AnalystBriefing/swine-Flu-vaccination market.asp
Contact our representative to sponsor this report
MarketsandMarkets is a research and consulting firm that publishes 120 market research reports per year. Each strategically analyzed report contains in-depth, five-level segmentation for each of the products, services, applications, technologies, ingredients and stakeholders categories. Our reports also analyze about 200 patents, over 40 companies and micro markets that are mutually exclusive and collectively exhaustive. Browse all our 120 titles at www.marketsandmarkets.com.
http://www.mytripledub.com/blog/health-medicine/marketsandmarkets-h1n1-swine-flu-influenza-vaccine-market-worth-us-7028-million
Sunday, February 7, 2010
Swine flu pandemic hit European children: study
Swine flu pandemic hit European children: study
Early reports showed about a 28 percent rise in deaths among children aged 5 to 14 in eight countries, Anne Mazick of the Statens Serum Institut in Copenhagen, Denmark and colleagues found.
This added up to about 77 deaths above what would normally be seen in that age group in those months, they reported in the online journal Eurosurveillance at eurosurveillance.org/ViewArticle.aspx?ArticleId=19480.
Estimating deaths from influenza is tricky, as most people are never tested, deaths cannot always be linked to flu and the cases of death are not always clearly reported. "This estimate is probably conservative due to delay in reporting," the European researchers added.
Mazick and colleagues pooled data from Belgium, Denmark, Greece, the Hesse region of Germany, Malta, Netherlands, Sweden and Switzerland -- a population of 66.8 million people.
"Our preliminary data show that the mortality reported during the 2009 influenza pandemic did not reach levels normally seen during seasonal influenza epidemics," the researchers wrote.
But they found 77 extra deaths among the 5- to 14-year-olds above what would normally be seen during that time.
"The steep rise of deaths after week 41 coincided with widespread pandemic influenza activity in the participating countries," they wrote.
"An excess number of 77 deaths corresponds roughly to a 28 percent increase in mortality among children 5-14 years old coinciding with the pandemic."
In comparison, the United States, with 300 million people, has confirmed more than 300 child deaths from H1N1 and says there were likely far more. That is more than double the numbers seen during the annual seasonal flu epidemic.
http://www.mytripledub.com/node/6454
Early reports showed about a 28 percent rise in deaths among children aged 5 to 14 in eight countries, Anne Mazick of the Statens Serum Institut in Copenhagen, Denmark and colleagues found.
This added up to about 77 deaths above what would normally be seen in that age group in those months, they reported in the online journal Eurosurveillance at eurosurveillance.org/ViewArticle.aspx?ArticleId=19480.
Estimating deaths from influenza is tricky, as most people are never tested, deaths cannot always be linked to flu and the cases of death are not always clearly reported. "This estimate is probably conservative due to delay in reporting," the European researchers added.
Mazick and colleagues pooled data from Belgium, Denmark, Greece, the Hesse region of Germany, Malta, Netherlands, Sweden and Switzerland -- a population of 66.8 million people.
"Our preliminary data show that the mortality reported during the 2009 influenza pandemic did not reach levels normally seen during seasonal influenza epidemics," the researchers wrote.
But they found 77 extra deaths among the 5- to 14-year-olds above what would normally be seen during that time.
"The steep rise of deaths after week 41 coincided with widespread pandemic influenza activity in the participating countries," they wrote.
"An excess number of 77 deaths corresponds roughly to a 28 percent increase in mortality among children 5-14 years old coinciding with the pandemic."
In comparison, the United States, with 300 million people, has confirmed more than 300 child deaths from H1N1 and says there were likely far more. That is more than double the numbers seen during the annual seasonal flu epidemic.
http://www.mytripledub.com/node/6454
Subscribe to:
Posts (Atom)